Financials
Income statement
Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
---|---|---|---|---|
Total reported revenue | 6.3B | 6.8B | 6.5B | 6.0B |
Cost of revenue | 4.1B | 4.6B | 4.3B | 3.8B |
Gross profit | 2.2B | 2.2B | 2.2B | 2.2B |
Operating expense | ||||
Research & development | — | — | — | — |
Selling general and admin | 367M | 104M | 330M | 353M |
Other operating expenses | -5M | 228M | -5M | — |
Operating income | 402M | 419M | 455M | 402M |
Non operating interest income | ||||
Income | 12M | 2M | 6M | 9M |
Expense | 10M | -5M | 12M | 16M |
Other income expense | — | — | — | — |
Pretax income | 405M | 420M | 451M | 397M |
Tax provision | 102M | 105M | 112M | 99M |
Net income | 303M | 315M | 339M | 298M |
Basic EPS | 2.5 | — | 2.7 | 2.4 |
Diluted EPS | 2.5 | — | 2.7 | 2.4 |
Basic average shares | 118.8M | — | 118.2M | 118.0M |
Diluted average shares | 118.8M | — | 118.7M | 118.5M |
EBITDA | 640M | 626M | 669M | 620M |
Net income from continuing op. | 303M | 315M | 339M | 298M |
Minority interests | -12M | -19M | -15M | -10M |
Preferred stock dividends | 0 | 0 | 0 | 0 |